Key result
Review summarizes major 2023-2024 trials and registries for structural heart disease interventions.
Why the study?
A surge in structural heart disease research prompted a comprehensive overview of the field for general and interventional cardiologists.
Provides a comprehensive overview of the most important structural heart disease research and trials from 2023-2024.
Provides clinicians a 2023-2024 structural heart evidence snapshot; leaves open practice integration pending prospective validation.
In 2023-2024, there was a surge in research on structural heart disease. This review aims to provide a comprehensive overview of the field for both general and interventional cardiologists, especially those with a keen interest in structural heart interventions. It summarizes the most important randomized controlled trials, meta-analyses, retrospective analyses, data registries, and noteworthy late-breaking studies unveiled at prominent cardiology conferences.
No takes yet. Share an insight, caveat, or question.
Marmagkiolis et al. (2025) conducted a review in Structural heart disease. Structural heart disease interventions was evaluated. This review provides a comprehensive overview of the most important randomized controlled trials, meta-analyses, and registries regarding structural heart disease interventions in 2023-2024.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: